Cardiovascular Risk Semaglutide has proven cardiovascular benefits
This risk is not exclusive to GLP-1 medications
In weight loss trials, a substantial proportion of patients regained a significant amount of weight within a year of stopping GLP-1RAs
Doctors often prescribe these medications to help with weight management
Results Disclaimer: Individual results vary based on baseline health status, specific health goals, protocol adherence, and numerous other factors
GHK-Cu and Perimenopause: What the Evidence Actually Shows About the Copper Peptide for Skin, Hair, and Collagen Written and edited by Sarah Bonza, MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC A patient came into my office a few months ago, opened a folder on her phone, and showed me a long list of skincare products she had been cycling through for the past two years